Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:patches
|
| gptkbp:administered_by |
licensed healthcare professional
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinical_trial |
Phase 3
demonstrated efficacy demonstrated safety |
| gptkbp:clinical_use |
cosmetic procedure
|
| gptkbp:contains |
hyaluronic acid
|
| gptkbp:contraindication |
bleeding disorders
active skin infection allergy to hyaluronic acid |
| gptkbp:customer_satisfaction |
high
|
| gptkbp:duration |
up to 18 months
|
| gptkbp:duration_of_procedure |
30 minutes
|
| gptkbp:events |
monitor for side effects
|
| gptkbp:formulation |
injectable gel
|
| https://www.w3.org/2000/01/rdf-schema#label |
Juvederm Vollure
|
| gptkbp:indication |
lip enhancement
facial volume loss |
| gptkbp:ingredients |
hyaluronic acid
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:market_position |
worldwide
|
| gptkbp:marketed_as |
gptkb:Vollure_XC
|
| gptkbp:packaging |
syringe
|
| gptkbp:pain_management |
ice pack
topical anesthetic |
| gptkbp:patient_education |
discuss risks and benefits
aftercare instructions provided |
| gptkbp:patient_population |
adults
|
| gptkbp:premiered_on |
immediate
|
| gptkbp:price |
varies by provider
|
| gptkbp:product_line |
gptkb:Juvederm
|
| gptkbp:provides_guidance_on |
informed consent required
follow manufacturer instructions assess patient history |
| gptkbp:recommissioned |
not required
|
| gptkbp:regulatory_compliance |
gptkb:CE_mark
Health Canada approval |
| gptkbp:shelf_life |
2 years
|
| gptkbp:side_effect |
bruising
swelling recommended redness pain at injection site |
| gptkbp:specialties |
ice application
avoid sun exposure avoid strenuous exercise |
| gptkbp:storage |
room temperature
|
| gptkbp:training |
for injectors
|
| gptkbp:used_for |
facial wrinkles
|
| gptkbp:variant |
different formulations available
|
| gptkbp:website |
lips
nasolabial folds linear threading serial puncture |
| gptkbp:bfsParent |
gptkb:Juvederm
|
| gptkbp:bfsLayer |
6
|